Showing results (231-240 of 255) with videos related to
Sort By:
Pageof 26
Cancers|January 10, 2026
Detection of Human Papillomavirus (HPV) in HPV-Associated Oropharyngeal Squamous Cell Carcinoma: A Review of Diagnostic Approach and Its Importance for the Head and Neck OncologistAmanda J Bastien, Daniel Manzoor, Evan S Walgama, et al.Cancer|June 23, 2017
Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancerJohn M David, Allen S Ho, Michael Luu, et al.JAMA Oncology|August 21, 2020
Comparison of Survival After Transoral Robotic Surgery vs Nonrobotic Surgery in Patients With Early-Stage Oropharyngeal Squamous Cell CarcinomaAnthony T Nguyen, Michael Luu, Jon Mallen-St Clair, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2018
Quantitative lymph node burden as a 'very-high-risk' factor identifying head and neck cancer patients benefiting from postoperative chemoradiationZ S Zumsteg, M Luu, S Kim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2017
Metastatic Lymph Node Burden and Survival in Oral Cavity CancerAllen S Ho, Sungjin Kim, Mourad Tighiouart, et al.The Journal of Biological Chemistry|April 29, 1994
Isotype choice for chimeric antibodies affects binding propertiesM M Morelock, R Rothlein, S M Bright, et al.The Laryngoscope|September 2, 2022
Predicting Pathologic Lymph Node Positivity in cN0 Pharynx and Larynx CancersEric M Anderson, Michael Luu, Diana J Lu, et al.Head & Neck|December 10, 2020
Variations in the association of grade with survival across the head and neck cancer landscapeEric M Anderson, Michael Luu, Bonnie L Balzer, et al.Cancer|May 10, 2018
Quantitative survival impact of composite treatment delays in head and neck cancerAllen S Ho, Sungjin Kim, Mourad Tighiouart, et al.Cancer|September 20, 2019
Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments?Emi J Yoshida, Michael Luu, Jon Mallen-St Clair, et al.Pageof 26